FASLG and neoplasm: Compared to control and sham-HIFU groups, the number of Fas ligand<sup>+</sup> and perforin<sup>+</sup> tumor-infiltrating lymphocytes (TILs) and apoptotic H<sub>22</sub> tumor cells were significantly higher (<i>p</i> < 0.001) in the HIFU group.